Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Tina Biss

Newcastle AuthorsTitleYearFull text
Dr Tina Biss
Dr Caroline Grayson
Haematological evaluation of bruising and bleeding in children undergoing child protection investigation for possible physical maltreatment: A British Society for Haematology Good Practice Paper2022
Dr Emma Kampouraki
Dr Peter Avery
Dr Tina Biss
Dr Hilary Wynne
Professor Farhad Kamali
Assessment of exposure to direct oral anticoagulants in elderly hospitalised patients2021
Dr Emma Kampouraki
Dr Salah Abohelaika
Dr Peter Avery
Dr Tina Biss
Dr Hilary Wynne
et al.		Elderly people are inherently sensitive to the pharmacological activity of rivaroxaban: implications for DOAC prescribing2021
Dr Tina Biss
Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (Einstein-Jr CVT)2020
Dr Tina Biss
Severity and Features of Epistaxis in Children with a Mucocutaneous Bleeding Disorder2018
Dr Tina Biss
Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura2017
Dr Tina Biss
Challenges in adolescent venous thromboembolism2016
Salah Abohelaika
Dr Tina Biss
Dr Hilary Wynne
Professor Farhad Kamali
C0170: The Impact of Dietary Vitamin K on the Pharmacological Activity of FXa Inhibitor Rivaroxaban in Man2014
Dr Tina Biss
Professor Farhad Kamali
Characterizing variability in warfarin dose requirements in children using modelling and simulation2014
Dr Tina Biss
Bruce Jaffray
Risk Stratification for the Use of Thromboprophylaxis in Young People With IBD Requires Further Evaluation2014
Salah Abohelaika
Dr Tina Biss
Dr Peter Murphy
Professor Farhad Kamali
The impact of dietary vitamin K on the pharmacological activity of FXa inhibitor rivaroxaban in man2014
Dr Tina Biss
Dr Peter Avery
Professor Farhad Kamali
The VKORC1 and CYP2C9 genotypes are associated with over-anticoagulation during initiation of warfarin therapy in children2013
Dr Tina Biss
Dr Peter Avery
Julian Leathart
Professor Farhad Kamali
VKORC1 and CYP2C9 genotype is associated with over-anticoagulation during initiation of warfarin therapy in children2012
Dr Tina Biss
Professor Farhad Kamali
Warfarin anticoagulation in children: is there a role for a personalized approach to dosing?2012
Dr Tina Biss
Dr Peter Avery
Professor Farhad Kamali
Warfarin dose prediction in children using pharmacogenetics information2012
123